Integrated efficacy and safety exposure response (ER) analysis of tivozanib (TIVO) for the treatment of renal cell cancer (RCC).Bradley A. McGregor, Robert J. Motzer, Toni K. Choueiri et al.|Journal of Clinical Oncology|2025Cited by 0
46Integrated efficacy and safety exposure response (ER) analysis of tivozanib (TIVO) for the treatment of renal cell cancer (RCC)Bradley A. McGregor, Robert J. Motzer, Philippe Barthélémy et al.|The Oncologist|2025Cited by 0